Market Cap 186.66B P/E 29.14 EPS this Y -0.10% Ern Qtrly Grth -6.90%
Income 6.09B Forward P/E 22.61 EPS next Y 8.70% 50D Avg Chg 4.00%
Sales 25.49B PEG 1.91 EPS past 5Y 16.66% 200D Avg Chg 8.00%
Dividend 2.00% Price/Book 25.65 EPS next 5Y 12.37% 52W High Chg -11.00%
Recommedations 2.10 Quick Ratio 0.83 Shares Outstanding 0.96B 52W Low Chg 51.00%
Insider Own 0.15% ROA 10.08% Shares Float 854.98M Beta 0.25
Inst Own 84.03% ROE 118.34% Shares Shorted/Prior 8.91M/7.72M Price 194.63
Gross Margin 75.88% Profit Margin 23.91% Avg. Volume 3,383,393 Target Price 213.41
Oper. Margin 27.83% Earnings Aug 3 Volume 1,654,829 Change -0.46%
Eli Lilly and Company News
09:12 AM Lilly's (LLY) Tyvyt BLA Accepted for Review by FDA for NSCLC
05:35 AM Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA
05/17/21 U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
05/16/21 Top Insider Buys Highlight for the Week of May 14
05/14/21 Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
05/13/21 Novo Nordisk, Eli Lilly Obesity Drugs Could Be Game Changers
05/13/21 Lilly to Participate in UBS Global Healthcare Virtual Conference
05/13/21 New Strong Sell Stocks for May 13th
05/11/21 Lilly, MiNA Ink Broad RNA Deal Worth $1.25B
05/11/21 New Strong Sell Stocks for May 11th
05/11/21 Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
05/10/21 Biden's Budget May Boost These 3 Biotechs
05/09/21 UPDATE 2-Eli Lilly signs deals to boost supply of COVID-19 treatment in India
05/09/21 Eli Lilly signs deals to boost supply of COVID-19 treatment in India
05/09/21 Should You Buy Eli Lilly and Company (NYSE:LLY) For Its Upcoming Dividend?
05/06/21 United Therapeutics (UTHR) Q1 Earnings Miss, Sales Beat
05/06/21 Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
05/06/21 These Top 2 Healthcare Companies Are in a Race to Riches
05/05/21 AmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of Expectations

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

LLY Chatroom

User Image inchartitrust Posted - 3 hours ago

$LLY breaks down from the curve. Sweet. I am still waiting.

User Image TradeWithAlerts Posted - 4 hours ago

πŸ‘πŸ»πŸ‘πŸ½πŸ‘πŸΏ Nice Print for $LLY - Amount: $38,926,000.00 - to learn more, take a training https://tradewithalerts.com/training OR if you know trading around prints sign up.

User Image tickeron Posted - 4 hours ago

What do you think of this? $LLY's price moved above its 50-day Moving Average on May 5, 2021. View odds for this and other indicators: https://srnk.us/go/2746362

User Image TradeWithAlerts Posted - 4 hours ago

πŸ‘πŸ»πŸ‘πŸ½πŸ‘πŸΏ Nice Print for $LLY - Amount: $87,992,223.00 - to learn more, take a training https://tradewithalerts.com/training OR if you know trading around prints sign up.

User Image LivStocksMkt Posted - 7 hours ago

$IBIO successfully resolved its lawsuit with Fraunhofer USA. $MRK $LLY $CELG

User Image LivStocksMkt Posted - 7 hours ago

$IBIO IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection. $LLY $MRK $GILD $BIIB

User Image SweepCast Posted - 8 hours ago

SweepCast alerted: $LLY with Unusual Options Activity Alerted on $210 CALL Expiring: 06-18-2021 worth 35KπŸ‚ |🎯 Visit https://www.sweepcast.com/optionflow?symbol=LLY&name=CALL&strike=$210&type=SWEEP&pre=$35K&exp=06-18-2021 🎯 |

User Image Focrs Posted - 9 hours ago

$LLY 200 soon

User Image LivStocksMkt Posted - 9 hours ago

$IBIO iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement https://www.globenewswire.com/news-release/2021/05/04/2222917/0/en/iBio-and-Fraunhofer-USA-Conclude-Litigation-and-Enter-License-Agreement.html $JNJ $LLY $MRK

User Image YODL Posted - 11 hours ago

$LLY p

User Image AroonOscar22 Posted - 11 hours ago

$SNDL $DHR $GILD $GSK $LLY

User Image briefingcom Posted - 12 hours ago

$LLY receives FDA acceptance for Sintilimab in combination with Pemetrexed and platinum chemotherapy for the first-line treatment of people with nonsquamous non-small cell lung cancer https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20210518050648LLY

User Image Newsfilter Posted - 13 hours ago

$LLY Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA https://newsfilter.io/a/ff6dd164ee5688fb6a64705c83171cc3

User Image STCKPRO Posted - 13 hours ago

$LLY NEW ARTICLE : Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA https://www.stck.pro/news/LLY/12993988

User Image Insider_Analysis Posted - 16 hours ago

$LLY In the recent reporting quarter: 498 institutions increased their position, while 592 decreased https://insider-analysis.com/search_whales.php?ticker=TABLE_LLY

User Image SweepCast Posted - 17 hours ago

SweepCast alerted: $LLY with Unusual Options Activity Alerted on $210 CALL Expiring: 06-18-2021 worth 35KπŸ‚ |🎯 Visit https://www.sweepcast.com/optionflow?symbol=LLY&name=CALL&strike=$210&type=SWEEP&pre=$35K&exp=06-18-2021 🎯 |

User Image otcdynamics Posted - 19 hours ago

$LLY U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer https://www.otcdynamics.com/lly-u-s-fda-accepts-regulatory-submission-for-sintilimab-in-combination-with-pemetrexed-and-platinum-chemotherapy-for-the-first-line-treatment-of-people-with-nonsquamous-non-small-cell-lung-

User Image Newsfilter Posted - 19 hours ago

$LLY FDA accepts Lilly, Innovent's sintilimab + chemotherapy application in lung cancer https://newsfilter.io/a/7b41125ae9ffd332b255259693aff5a0

User Image fla Posted - 20 hours ago

$LLY [15s. delayed]: Issued Press Release on May 18, 00:09:00: U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with P https://s.flashalert.me/1pM6z

User Image STCKPRO Posted - 20 hours ago

$LLY NEW ARTICLE : U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer https://www.stck.pro/news/LLY/12988191

User Image Stock_Titan Posted - 20 hours ago

$IVBIY $LLY U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer https://www.stocktitan.net/news/IVBIY/u-s-fda-accepts-regulatory-submission-for-sintilimab-in-combination-qxo6hb96mypw.html #cancer

User Image Newsfilter Posted - 20 hours ago

$IVBIY $LLY U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung C.. https://newsfilter.io/a/71d9a0fda55c9d31a2435cd803b68a5b

User Image Quantisnow Posted - 20 hours ago

$LLY πŸ“° U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer https://quantisnow.com/insight/753299?s=s #majorpharmaceuticals #healthcare

User Image SweepCast Posted - 22 hours ago

SweepCast alerted: $LLY with Unusual Options Activity Alerted on $210 CALL Expiring: 06-18-2021 worth 35KπŸ‚ |🎯 Visit https://www.sweepcast.com/optionflow?symbol=LLY&name=CALL&strike=$210&type=SWEEP&pre=$35K&exp=06-18-2021 🎯 |

User Image CZARBETS Posted - 1 day ago

$LLY institutional ownership down 0.3% from 83.3% to 83%

User Image EVchargingpro Posted - 1 day ago

$VYNT let’s get this right tomorrow we are doing β€œbio partnering conference” Then ceo said in earnings comment they have been seeking a partner with upfront payments and royalties $LLY has already partnered with them! DPW now took a position in VYNT and they have up to 50 million to invest they tend to do 13d and bring value to investors hmhm $BTX

User Image EVchargingpro Posted - 1 day ago

$VYNT 33 million cash on hand expecting massive PR tomorrow regarding their conference! Market cap of 97 million! This stock has a partnership with $LLY tomorrow should be wild! $DPW is now long $VYNT into the conference tomorrow! They announced this in the last seconds of their show link here https://m.youtube.com/watch?v=pjHZq13dFs0

User Image TradeWithAlerts Posted - 1 day ago

New Print for $LLY - Amount: $36,894,946.76 - to learn more, take a training https://tradewithalerts.com/training OR if you know trading around prints sign up.

User Image EVchargingpro Posted - 1 day ago

$VYNT for everyone asking about price target if $LLY extends their partnership with us or if $BMY starts a new partnership with us short term we see 8-12 and long term we see $90 and u can hold on for years and just borrow against ur holding and buy a house with it!

User Image AroonOscar22 Posted - 1 day ago

$SNDL $BA $CMI $EMR $LLY https://media0.giphy.com/media/VHsrIjQiw1zfoR1qbv/giphy.gif?cid=790b7611c9e3282e16fb09ebcf9689de74848e87db23f16f&rid=giphy.gif&ct=g 5% Gain Today

Analyst Ratings
Morgan Stanley Overweight Apr 28, 21
Mizuho Buy Apr 28, 21
Barclays Overweight Apr 28, 21
Truist Securities Buy Mar 15, 21
Cowen & Co. Outperform Feb 12, 21
Morgan Stanley Overweight Feb 4, 21
Truist Securities Buy Feb 1, 21
Mizuho Buy Feb 1, 21
B of A Securities Buy Jan 22, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
TAI JACKSON P Director Director May 3, 7:01 PM Buy 182.87 1,366 249,800 61,195
LILLY ENDOWMENT INC 10% Owner 10% Owner Jan 12, 11:27 AM Sell 186.24 220,000 40,972,800 110,912,343